Highlights from ASCO20 Virtual: Lung Cancer - a podcast by OncologyEducation

from 2020-06-24T22:38:12

:: ::

This episode features Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Jeffrey Rothenstein.

This program was made possible by unrestricted sponsorship support from AstraZeneca.

Trials Discussed:

  1. Adjuvant NSCLC: CTONG 1104 & ADAURA: 00:01:11
  2. Metastatic NSCLC: NEJ026, CONCURRENT OSIMERTINIB/GEFITINIB, JNJ-61186372, OSIMERTINIB 160MG, Poziotinib in previously treated EGFR exon 20 NSCLC patients: 00:17:21
  3. Stage IV NSCLC, Target HER2: T-Dxd DESTINY-LUNG01, GEOMETRY, Sym015, METex14 SA and potential AR mechanisms: 00:26:25
  4. Immunotherapy Updates in NSCLC: CHECKMATE 227 3 YEAR, CHECKMATE 9LA, CCTG BR34: 00:42:35
  5. Extensive Stage SCLC: ECOG-ACRIN EA5161, KEYNOTE-604 & CASPIAN: 00:55:28

Further episodes of Best of Oncology Podcast Series

Further podcasts by OncologyEducation

Website of OncologyEducation